Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

VC Roundup: Moderna Seeks Another Record-Breaking Raise; Arcus Emerges From Stealth Mode

Executive Summary

Having raised a precedent-setting $450m venture capital round in January 2015, Moderna is well on its way to a planned $600m additional fundraising. The privately held company is keeping quiet about what it's doing with all that cash. Tioma, Nutrina and Avelas are among other firms receiving VC financing.

Advertisement

Related Content

Finance Watch: A Bountiful November Harvest For Venture-Backed Biopharma
Deal Watch: AZ Ups mRNA Stake, Gilead's HIV Innovation, Hospira Returns Lucentis Biosimilar, Pfizer/Takeda End Distribution Deal
Moderna Signs Single Drug Deal With CF Expert Vertex For Up To $315m
Merck Bets Moderna's Cancer Vaccines Can Prime Patients For Immunotherapy
Indian Start-up Vyome Wins Milestone FDA Nod For Acne Studies
Flexus flips IDO inhibitors to Bristol-Myers for up to $1.25bn
Venture Funding Deals, February 2015
Moderna raises $450m; most ever for private biotech
Reading between the lines of J&J's $1.75bn Alios buy
Amgen Paying $1.3 Bil. For Tularik; Deal Brings Two Late-Stage Oncologics

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC097213

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel